CMI Inc. and Life Molecular Imaging Announce the Reimbursement of the Amyloid-PET Diagnostic Neuraceq® (florbetaben 18F) in Japan

/PRNewswire/ -- CMI Inc. and Life Molecular Imaging (LMI) are pleased to announce that the amyloid-PET diagnostic Neuraceq® (florbetaben 18F injection) has...

Related Keywords

Berlin ,Germany ,South Africa ,Tokyo ,Japan ,Johannesburg ,Gauteng ,Kyoto ,South African ,Japanese ,Colleen Ruby ,Yasuhisa Fujibayashi ,Ludger Dinkelborg ,Johannesburg Stock Exchange ,Life Healthcare Group ,Brittany Hahn Marketing Communications ,Keio University Hospital ,Ministry Of Health ,First Reimbursed Amyloid ,Life Molecular Imaging ,Koseikai Takeda Hospital ,Uozumi Clinic ,Managing Director ,Life Molecular ,Chief Operating Officer ,Chief Technology Officer ,Positron Emission Tomography ,Safety Information ,Image Interpretation ,Molecular Imaging ,Piramal Imaging ,Bayer Pharma ,Life Healthcare ,Johannesburg Stock ,Marketing Communications Manager ,Health Care Amp Hospitals ,Medical Pharmaceuticals ,Medical Equipment ,Pharmaceuticals ,Biotechnology ,Licensing ,